Literature DB >> 12206153

The usefulness of serum adenosine deaminase 2 (ADA2) activity in adults for the diagnosis of pulmonary tuberculosis.

M B Conde1, S R Marinho, M de Fatima Pereira, J R Lapa e Silva, M H F Saad, C L Sales, J L Ho, A L Kritski.   

Abstract

Rapid diagnosis of Mycobacterium tuberculosis remains an obstacle for therapy of tuberculosis (TB). Adenosine deaminase isoform 2 (ADA2) is produced by activated macrophages and has been used for diagnosis of TB from extra-pulmonary sites. However, few studies adequately address whether serum ADA2 activity is useful for diagnosis of active pulmonary tuberculosis (PTB). We prospectively measured serum ADA2 activity in 110 patients with pulmonary disease (65 cases with active PTB and 45 cases with other respiratory diseases) and 78 healthy volunteers (eight with tuberculin skin test positive). The serum ADA2 for the diagnosis of PTB had the sensitivity of 36.9%, the specificity of 84.5%, the positive predictive value of 10.9% and the negative predictive value of 96.2%. We concluded that serum ADA2 activity is neither useful to diagnosis of active PTB nor to differentiate from other respiratory diseases.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12206153     DOI: 10.1053/rmed.2001.1273

Source DB:  PubMed          Journal:  Respir Med        ISSN: 0954-6111            Impact factor:   3.415


  7 in total

1.  Differential diagnosis of tuberculous and malignant pleural effusions: what is the role of adenosine deaminase?

Authors:  Bojan Zarić; Vesna Kuruc; Aleksandar Milovančev; Marica Markovic; Tatjana Šarčev; Vukašin Čanak; Slobodan Pavlović
Journal:  Lung       Date:  2008-03-21       Impact factor: 2.584

2.  Determination of serum adenosine deaminase and xanthine oxidase levels in patients with crimean-congo hemorrhagic fever.

Authors:  V Kenan Celik; Ismail Sari; Aynur Engin; Yildiz Gürsel; Hüseyin Aydin; Sevtap Bakir
Journal:  Clinics (Sao Paulo)       Date:  2010-07       Impact factor: 2.365

3.  Validity of serum adenosine deaminase in diagnosis of tuberculosis.

Authors:  Aliasghar Farazi; Ayda Moharamkhani; Masoome Sofian
Journal:  Pan Afr Med J       Date:  2013-08-14

4.  Changes of serum adenosine deaminase level in new cases of pulmonary tuberculosis before and after intensive phase treatment.

Authors:  Soedarsono Soedarsono; Kana Wulung Arie Ichida Prinasetyo; Mayfanny Tanzilia; Jusak Nugraha
Journal:  Lung India       Date:  2020 Mar-Apr

5.  Adenosine deaminase 2 produced by infiltrative monocytes promotes liver fibrosis in nonalcoholic fatty liver disease.

Authors:  Shilpa Tiwari-Heckler; Eric U Yee; Yusuf Yalcin; Jiwoon Park; Duc-Huy T Nguyen; Wenda Gao; Eva Csizmadia; Nezam Afdhal; Kenneth J Mukamal; Simon C Robson; Michelle Lai; Robert E Schwartz; Z Gordon Jiang
Journal:  Cell Rep       Date:  2021-10-26       Impact factor: 9.423

6.  Diagnostic value of serum adenosine deaminase level in pulmonary tuberculosis.

Authors:  Shahla Afrasiabian; Behzad Mohsenpour; Katayoun Haji Bagheri; Naseh Sigari; Kaveh Aftabi
Journal:  J Res Med Sci       Date:  2013-03       Impact factor: 1.852

7.  Serum Biomarker Profile Including CCL1, CXCL10, VEGF, and Adenosine Deaminase Activity Distinguishes Active From Remotely Acquired Latent Tuberculosis.

Authors:  Eveline M Delemarre; Laura van Hoorn; Aik W J Bossink; Julia Drylewicz; Simone A Joosten; Tom H M Ottenhoff; Onno W Akkerman; Delia Goletti; Elisa Petruccioli; Assunta Navarra; Brigitte T A van den Broek; Sanne P A Paardekooper; Ineke van Haeften; Leo Koenderman; Jan-Willem J Lammers; Steven F T Thijsen; Regina W Hofland; Stefan Nierkens
Journal:  Front Immunol       Date:  2021-10-07       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.